Hospitalizations linked to cannabinoid hyperemesis syndrome (CHS)—a condition associated with frequent, long-term use of marijuana—doubled from 2017 to 2021. Researchers are still trying to understand what makes some people so vulnerable to CHS.
2024-11-12 1334词 晦涩
First described in 2004 by doctors in Australia, CHS affects an estimated 2.75 million people in the U.S. each year, and cases are rising: According to research in an October 2024 issue of JAMA, emergency department visits related to CHS doubled in the U.S. and Canada from 2017 to 2021.
免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。